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The present study empirically assessed the rela-
tionships between adherence behaviors and HRQOL,
parent and child psychological functioning and fam-
ily functioning, and investigated the relationship be-
tween adherence behaviors and health outcomes in
children who were within 5 years of their liver trans-
plantation. Participants included 38 children (mean =
8.5 years, range 28 months to 16 years) and their par-
ent/guardian(s). HRQOL and psychological function-
ing were examined using well-validated assessment
measures. Measures of adherence included the rate
of clinic attendance and standard deviations (SDs) of
consecutive tacrolimus blood levels, which were col-
lected and evaluated retrospectively. Measures of child
health status included the frequency of hospital ad-
missions, liver biopsies, episodes of rejection and graft
function for the year prior to study participation. Re-
sults indicated that nonadherence was related to lower
physical HRQOL, more limitations in social and school
activities related to emotional and behavioral prob-
lems, parental emotional distress and decreased fam-
ily cohesion. Nonadherence was also related to fre-
quency and duration of hospitalizations, liver biopsies
and rejection episodes. These results suggest that em-
pirically based assessment of HRQOL, parenting stress
and family functioning may help identify patients at
risk for nonadherence, and may allow for the need-
based delivery of appropriate clinical interventions.
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Introduction
Post-transplant medical regimen adherence is essential for
long-term graft survival, and poor adherence with post-
transplant immunosuppressant medications is associated
with increased medical complications, graft rejection, post-
transplant mortality and increased health care utilization
rates (1–4). Among pediatric liver transplant (LT) popula-
tions, nonadherence with post-operative medical regimens
is estimated to be as high as 50% and contributes to more
graft loss than uncontrolled rejection in adherent patients
(3,4). These nonadherence rates are striking given that un-
like other post-transplant complications, adherence behav-
ior has the potential to be directly modifiable.
Given the severity of potential consequences of non-
adherence, adherence behavior should be the focus of
intervention. Before adherence-enhancing interventions
can be developed, it is necessary to identify factors re-
lated to nonadherence among pediatric transplant recip-
ients. Research with other pediatric chronic illness pop-
ulations have identified poor health-related quality of life
(HRQOL), parental psychological distress and disrupted
family functioning as key constructs related to nonad-
herence (5) (see Table 1). Few empirically sound studies
have examined these relationships in pediatric solid organ
transplantation.
A recent review of 11 published studies that examined
HRQOL in pediatric LT recipients suggested that LT re-
cipients had poorer quality of life in some areas of physi-
cal, psychological, social and family functioning when com-
pared to healthy peers, but equal to or better HRQOL than
children with other chronic illnesses (6–9). Yet, the extent
to which diminished HRQOL following transplant impacts
adherence remains unclear.
The few studies that have examined the psychosocial
functioning of parents of LT patients have demonstrated
that parents of LT recipients report more emotional distur-
bances, including symptoms of post-traumatic stress dis-
order (PTSD), anxiety and depression (9–12) and more dis-
rupted family activities than parents in the general popula-
tion (8). To date, there is only one published study examin-
ing the relationship between parent functioning and post-
transplant regimen adherence among LT recipients (11).
This study found that parent symptoms of PTSD were sig-
nificantly related to nonadherence as measured by clinician
panel and standard deviations (SDs) of tacrolimus blood
levels.
Regimen nonadherence has been linked to family variables
such as poor family cohesion and greater stress levels
1974
Psychological Functioning and Adherence
Table 1: Definitions of child HRQOL, parent and family functioning
Construct Definition Assessment tools
Health-related Quality
of Life (HRQOL)
HRQOL is a multi-dimensional concept that reflects the impact of
disease and treatment on an individual’s subjective evaluation of
his or her functioning and emotional well-being (28)
Pediatric Quality of Life
Inventory-Generic Core Scales
(PedsQL4.0) (14)
Measurement of HRQOL includes an assessment of physical
health, psychological health, social functioning, role (school)
functioning and general health perceptions
Child Health Questionnaire-Parent Form
50 (CHQ-PF50 c©) (15)
Child Psychological
Functioning
Emotional and behavioral functioning including the degree of
externalizing problems such as aggression, oppositional defiance,
delinquency, inattention, hyperactivity, and impulsivity and
internalizing behavior problems such as anxiety, depression,
social withdrawal




Anxiety, depression, and stress related to parenting a child with a
chronic illness
Brief Symptom Inventory (18)
Beck Depression Inventory (19)
Pediatric Inventory for Parents (PIP) (20)
CHQ-PF50 c©(15)
Family Functioning The frequency of disruption of usual family activities, effectiveness
of family communication and problem-solving, and degree of
family cohesiveness, or how well the family gets along with one
another
Family Assessment Device (21)
Family Environment Scale (FES) (22)
CHQ-PF50 c©(15)
(13). Yet, there is a lack of research investigating overall
family functioning among pediatric transplant populations.
Moreover, there are no published studies examining the
effect of family functioning on adherence in a pediatric LT
population.
The objectives of the current study were to assess the re-
lationships between adherence and HRQOL, parent and
child psychological functioning, and family functioning us-
ing empirically validated assessment measures, and to in-
vestigate the relationship between adherence and health
outcomes in children who were within 5 years of their
liver transplantation. It was hypothesized that poor child
HRQOL, poor child and parent psychological functioning
and disrupted family functioning would be associated with
nonadherence, and that increased rates of nonadherence
would be related to poor health outcomes.
Materials and Method
Participants
This protocol was approved by the Institutional Review Board of the Uni-
versity of Michigan Medical School. Participants were recruited from the
Pediatric Liver Transplant Clinic at the University of Michigan. All children
between the ages of 2–16 years, who were within 5 years of liver trans-
plantation, were eligible for participation if at least one parent/guardian was
fluent in English. Potential participants were identified by searching the
clinical database of the Organ Transplantation Information System at the
University of Michigan. Forty-five eligible participants were identified and
were recruited by mail and/or face-to-face contact during their clinic visit. Of
the eligible participants contacted, 38 (84%) agreed to participate. Seven
families declined participation due to time constraints and/or the presence
of other children at the clinic visit.
Procedures
Parent/guardian(s) and children (≥6 years old, n = 23) completed empir-
ically based, standardized assessment measures following their regularly
scheduled Pediatric Liver Transplant Clinic appointment. This assessment
battery evaluated HRQOL, parent and child psychological functioning and
family functioning using instruments considered to be the gold standard for
measuring these constructs (Table 2). The assessment battery was adminis-
tered by a pediatric psychologist (EMF), and questionnaires were reviewed
upon completion. Any parent or child who endorsed critical items or signif-
icant symptoms of a mental health disorder underwent an interview with
the psychologist, and were offered assistance in locating mental health
services. Measures of regimen adherence and health status were also ob-
tained from the child’s medical records. Families were reimbursed for their
time and effort devoted to study-related activities.
Measures
HRQOL: Pediatric Quality of Life Inventory-Generic Core Scales (PedsQL4.0
(14): The PedsQL is a well-validated modular instrument for measuring
HRQOL in children and adolescents. The PedsQL4.0 Core Scales is a 23-
item inventory that assesses physical, emotional, social and school func-
tioning. Parent-proxy report of HRQOL was measured for all participants,
and pediatric self-report was measured in children and adolescents older
than 6 years. Higher scores on this measure are indicative of more positive
HRQOL.
Child Health Questionnaire-Parent Form 50 (CHQ-PF50 c© (15): The CHQ-
PF50 is a 50-item empirically validated questionnaire completed by a par-
ent/caregiver. The instrument assesses a broad spectrum of child- and
family-focused health areas. Higher scores on this measure are indicative
of more positive health status.
Child psychological functioning: Child Behavior Checklist Parent Report
Form (CBCL/11/2–5, CBCL/6–18 (16,17). The CBCL forms are standardized
parent-report measures of behavioral problems and social competencies of
children. The CBCL/11/2 to 5 years is scored for Internalizing, Externalizing
and Total Problems and 7 syndromes. The CBCL/6–18 years is scored for
three competence scales (Activities, Social and School), Total Competence,
three summary scales (Internalizing, Externalizing and Total Problems), eight
empirically derived syndromes scales, and six DSM-oriented scales. In this
study, only scales that appear on both forms were used. High scores on
the summary, syndrome and DSM-oriented scales (T ≥ 63, 90th percentile)
are indicative of clinically significant disturbances, while low scores on the
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Table 2: Psychological and HRQOL assessment measures
Scales used
Measure in present study Sample question(s)
Pediatric Quality of Life Total functioning Items are rated on a 5-point Likert scale
Inventory-Generic Core Scales Physical functioning ‘In the last month, how much trouble have you (has your child) had
(PedsQL4.0) (14) Emotional functioning with . . .’
Social functioning • Participating in sports activity or exercise
School functioning • Feeling sad or blue
Child Health Questionnaire- Physical functioning • Keeping up with schoolwork
Parent Form 50 General health Items are rated on a Likert scale (4–6 point depending on subscale)







• Has your child’s school work or activities with friends been
limited in any of the following ways due to emotional difficulties
or problems with his/her behavior – limited in the kind of
schoolwork or activities with friends he/she could do; limited in
the amount of time he/she could spend on schoolwork or
activities with friends; limited in performing schoolwork or
activities with friends?
• How much of the time do you think your child: felt like crying;
felt lonely; acted nervous; bothered or upset; cheerful?
• How much emotional worry or concern did each of the
following cause you – your child’s physical health; emotional









Child Behavior Checklist Parent Internalizing, externalizing
and total problems
Items are rated on a 3-point scale
• Argues a lot
• Can’t concentrate
• Too fearful or anxious
• Unhappy, sad, depressed
• Doesn’t get along with other kids




















Brief Symptom Inventory (BSI)
(18)
Global Severity Index Respondents rate the perceived severity of 53 psychological and
physical symptoms on a 5-point scale ranging from 0 (‘not at all’)
to 4 (‘extremely’)
• Feeling tearful
• Trouble remembering things
• Feeling tense or keyed up
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Table 2: Continued
Scales used
Measure in present study Sample question(s)
Pediatric Inventory for Parents Communication Items are rated on a 5-point Likert Scale





‘How often has the event occurred for you in the past 7 days, and
how difficult it was/or generally is for you’
• Difficulty sleeping
• Arguing with family members
• Feeling confused about medical information
• Being with my child during medical procedures









Items are rated on a 4-point Likert scale from 1 (strongly agree) to 4
(strongly disagree)
• We resolve most everyday problems around the house
• We confront problems involving feelings
• Planning family activities is difficult because we misunderstand
each other
Family Environment Scale Cohesion Items are scored as True or False
(FES) (22) Conflict • Family members often keep their feelings to themselves
• Family members hardly ever lose their tempers
• We really get along well with each other
• We fight a lot in our family
competence scales (T < 37, <10th percentile) are indicative of functioning
in the clinically significant range.
Parent psychological functioning: Brief Symptom Inventory (18): Parents
completed the BSI, which is an abbreviated 53-item version of the Symptom
Checklist-90-Revised that assesses nine clinical dimensions of psychologi-
cal distress, and yields a Global Severity Index (GSI) used to assess overall
distress. Only the Global Severity Index was used in these analyses.
Beck Depression Inventory (19): Parents completed the BDI-II, which is a
21-item self-report measure used to assess depressive symptomatology.
Pediatric Inventory for Parents (20): Parents completed the PIP, which is
a 42-item measure of stress related to parenting a child with a chronic
illness. Items are grouped into four domain scales: Communication, Emo-
tional Functioning, Medical Care and Role Functioning. Parents rate each
item as to the item’s frequency over the past week and the level of diffi-
culty associated with it. Scale scores are combined for Total Frequency and
Total Difficulty scores. Higher scores indicate greater frequency and greater
difficulty.
Family functioning: Family Assessment Device (21): Parents completed
the FAD, which is a 60-item self-report measure that describes struc-
tural and organizational properties of the family and patterns of transaction
among family members. The FAD provides scores for six domains of family
functioning. Scaled scores range from 0 to 4 with a clinical cutoff of 2 (i.e.
scores of 2 or more indicate unhealthy functioning).
Family Environment Scale (22): Parents completed the Cohesion and Con-
flict subscales of the FES. These subscales assess the extent to which
family members are helpful, supportive and committed to one another, and
the extent to which conflictual interactions are characteristic of the family.
Adherence behaviors: Regimen adherence was evaluated retrospectively
using multiple indices. Definitions of adherence were determined using
stringent cut-offs based on previous research showing that minimal de-
viations from dosing schedule of the immunosuppressive regimens were
associated with an increase risk of poor clinical outcomes (23,24).
Clinic Attendance Adherence to clinic visits was assessed by comparing
clinic attendance to the number and interval frequency recommended by
the transplant team. The rate of clinic attendance was obtained from the
child’s medical record. Adherence was defined as a clinic attendance rate of
≥80%.This definition is consistent with the pediatric adherence literature
(25).
Immunosuppressant Levels To measure adherence to post-transplant im-
munosuppressant medications, data from routine monitoring of tacrolimus
blood levels were obtained from the child’s medical record. Tacrolimus lev-
els obtained during inpatient hospitalization stays were not included in the
analyses. Standard deviations (SDs) of consecutive trough tacrolimus blood
levels were calculated. Shemesh and colleagues have demonstrated the
predictive and concurrent validity of the use of SD of tacrolimus blood levels
as a measure of adherence to immunosuppressive medications (26). Specif-
ically, higher fluctuations have been used as an indicator of variable medica-
tion administration, and tacrolimus SD was significantly related to clinician
ratings of nonadherence, as well as health outcome including episodes of
rejection (26). In this study, adherence was defined as an SD <2.5.
Health status: Measures of child health status including graft function,
frequency of hospital admissions, liver biopsies and episodes of rejection
for the year prior to study participation were collected via patient medical
records.
Statistical method
Sample mean subscale and summary scores obtained on the psycholog-
ical measures were compared with published normative data for healthy
children and data from other pediatric chronic illness populations when pub-
lished norms were available using two-tailed t-tests. Correlations were used
to identify the relationships between scores on the psychosocial measures
and measures of post-transplant adherence and health outcomes. Pearson’s
product moment correlation coefficients were calculated whenever the as-
sumptions underlying parametric statistical testing were met. However, if
study measures exhibited frequency distributions which differed from the
normal distribution, Spearman’s rank correlation coefficient were used in-
stead. Participants were categorized as ‘adherent’ or ‘nonadherent’ based
on their rate of clinic attendance and tacrolimus SD. Two-sample t-tests
were used to assess differences between ‘adherent’ and ‘nonadherent’
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Table 3: Participant demographics
Factor Mean ± SD
Maternal age (years) 37.0 ± 7.8
Paternal age (years) 40.3 ± 6.8
Child’s age (months) 102.0 ± 44.7
Time since transplant 25.2 ± 17.7
(months)
Child gender Female = 20 (51.6%)
Male = 18 (47.4%)






Diagnosis Biliary atresia (44.7%)








participants with respect to the behavioral health measures, and health out-




Participants included 38 children (Mean = 8.5 years, range
28 months to 16 years) who were within 5 years of
liver transplantation (Mean time since transplant = 25.2
months, range 1–64 months) and their parent/guardian(s).
Ninety percent of parent respondents were mothers. Clin-
Table 4: PedsQL 4.0 parent proxy-report and child self-report for liver transplant recipients and comparisons with healthy children, and
children with chronic illness
Liver transplant Healthy∗ Cancer∗ Diabetes∗
Scale n Mean ± SD n Mean ± SD p-Value n Mean ± SD p-Value n Mean ± SD p-Value
Parent proxy report
Total score 38 65.00 ± 18.62 717 87.61 ± 12.33 0.0001 336 69.70 ± 19.17 ns 307 76.56 ± 14.10 0.0001
Physical health 38 64.97 ± 28.28 717 89.32 ± 16.35 0.0001 336 68.75 ± 24.98 ns 307 81.99 ± 17.22 0.001
Psychosocial health 38 64.76 ± 17.63 717 86.58 ± 12.79 0.0001 336 70.31 ± 17.96 ns 307 73.61 ± 15.37 0.004
Emotional functioning 38 66.32 ± 21.89 718 82.64 ± 17.54 0.0001 336 67.53 ± 20.32 ns 307 69.08 ± 18.57 ns
Social functioning 38 70.79 ± 21.01 716 91.56 ± 14.20 0.0001 336 75.64 ± 20.61 ns 305 81.03 ± 19.38 0.005
School functioning 38 56.63 ± 21.73 611 85.47 ± 17.61 0.0001 250 66.40 ± 23.19 0.012 299 70.8 ± 19.39 0.0001
Child self-report
Total score 23 69.82 ± 17.15 401 83.00 ± 14.79 0.001 219 72.20 ± 16.38 ns 300 80.37 ± 12.90 0.007
Physical health 23 69.46 ± 24.52 400 84.41 ± 17.26 0.008 219 71.79 ± 21.80 ns 300 85.95 ± 13.34 0.004
Psychosocial health 23 69.47 ± 16.94 399 82.38 ± 15.51 0.002 219 72.62 ± 16.41 ns 300 77.34 ± 14.62 0.041
Emotional functioning 23 76.52 ± 20.53 400 80.86 ± 19.64 ns 219 71.83 ± 21.44 ns 300 72.37 ± 19.57 ns
Social functioning 23 74.35 ± 20.52 399 87.42 ± 17.18 0.006 219 76.84 ± 20.31 ns 300 85.63 ± 16.24 0.015
School functioning 23 58.91 ± 22.05 386 78.63 ± 20.53 0.0001 191 68.51 ± 19.72 0.049 297 74.2 ± 18.08 0.003
∗Data for healthy children and children with chronic illness were retrieved from published references (29, 30).
NOTE: Scores range from 0 to 100, with higher scores reflecting better HRQOL.
ical and demographic information is provided in Table 3.
There were significant relationships between child age and
measures of parenting stress (PIP-F, r = –0.38, p = 0.019;
PIP-D, r = –0.41, p = 0.001), and tacrolimus SD (r = –0.37,
p = 0.038). Thus, all subsequent analyses controlled for
the effects of age. There were no significant relationships
between time since transplantation, race or other demo-
graphic variables and measures of psychosocial function-
ing, adherence or health status.
HRQOL
Based on parent proxy-reports on the PedsQL4.0, the
mean scores for total functioning, physical and psychoso-
cial health, emotional, social and school functioning were
all significantly lower in LT recipients as compared to pub-
lished norms for healthy children (p = 0.0001; See Table 4).
LT recipients had significantly lower school functioning
compared to normative data for children with cancer
(p = 0.012) and diabetes (p = 0.0001), and also had signifi-
cantly lower mean scores for total functioning (p = 0.0001),
physical functioning (p = 0.001), psychosocial health (p =
0.004) and social functioning (p = 0.005) compared to chil-
dren with diabetes.
Child self-reports on the PedsQL4.0 suggest that mean
scores for total functioning (p = 0.001), physical (p =
0.008), psychosocial health (p = 0.002), social (p = 0.006)
and school functioning (p = 0.0001) were significantly
lower in LT recipients as compared to published norms for
healthy children. Consistent with parental report, LT recip-
ients reported significantly lower school functioning than
children with cancer (p = 0.049) and diabetes (p = 0.003).
They also reported significantly lower total (p = 0.007),
physical (p = 0.004), psychosocial (p = 0.041), social
(p = 0.015) and school functioning (p = 0.003) than nor-
mative data for children with diabetes.
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Table 5: CHQ-PF50 Summary scores for liver transplant recipients compared to normative data for healthy population
Scales Liver transplant mean ± SD Healthy∗ mean ± SD Significance
Physical functioning 68.8 ± 34.9 96.1 ± 13.9 p = 0.0001
Role/Social–Emotional, behavioral 70.2 ± 32.3 92.5 ± 18.6 p = 0.0001
Role/Social–Physical 73.0 ± 37.5 93.6 ± 18.6 p = 0.002
Bodily pain 70.0 ± 28.9 81.7 ± 19.0 p = 0.017
General behavior 65.6 ± 21.0 75.6 ± 16.7 p = 0.006
Mental health 72.3 ± 13.5 78.5 ± 13.2 p = 0.008
Self esteem 75.4 ± 18.7 79.8 ± 17.5 p = 0.160
General health perceptions 43.1 ± 16.6 73.0 ± 17.3 p = 0.0001
Parental impact–time 58.3 ± 33.8 87.8 ± 19.9 p = 0.0001
Parental impact–emotional 46.9 ± 31.3 80.3 ± 17.3 p = 0.0001
Family activities 64.6 ± 24.6 89.7 ± 18.6 p = 0.0001
Family cohesion 71.1 ± 22.5 72.3 ± 8.8 p = 0.743
Physical functioning summary 36.4 ± 17.3 53.0 ± 8.8 p = 0.0001
Psychosocial functioning summary 43.7 ± 11.0 51.2 ± 9.1 p = 0.0001
Note: Individual scores range from 0 to 100, with higher scores reflecting better HRQOL.
∗Data for healthy population were retrieved from published references (15)
Table 5 presents means and standard deviations for the
subscales of the CHQ-PF50 for LT recipients compared
with healthy children population scores (15). Results from
the CHQ-PF50 indicate that physical and psychosocial
summary scores were significantly lower for LT recipi-
ents than for the general population (p = 0.0001). Com-
pared to the general population, LT recipients had sig-
nificantly lower scores on individual subscales including
physical functioning (p = 0.0001), role/social limitations-
emotional/behavioral (p = 0.0001), role/social limitations-
physical (p = 0.002), bodily pain (p = 0.017), general be-
havior (p = 0.006), mental health (p = 0.008) and general
health perceptions (p = 0.0001).
Child psychological functioning
Parent reports on the CBCL indicated that aggre-
gate scores on the summary scales (Total Problems,
Internalizing Problems, Externalizing Problems) for the LT
group as a whole were not clinically elevated, and with the
exception of Internalizing Problems (p = 0.029), the To-
tal and Externalizing Problems scales did not differ signif-
icantly from norms for healthy children. Aggregate scores
for CBCL subscales were not in the clinically significant
range, but they did differ significantly from norms for
healthy children (see Table 6). Further analyses of the
CBCL results revealed that compared to normative data
for healthy children, wherein 7% were in the clinical range
on summary scales and subscales (16), a disproportion-
ate number of LT recipients exceeded clinical cutoffs on
all summary scales and subscales (Table 6). Compared to
25–30% of children in the normative sample, 60.5% of LT
recipients were within the clinical range on Internalizing
and/or Externalizing, Total Problems and at least one clini-
cal subscale.
Parent psychological functioning
Global measures of parent functioning (BDI-II, BSI) were
within the normal range and did not differ significantly from
normative data for the general population. Parent reports
on subscales of the CHQ-PF50 that assess parent function-
ing related to child HRQOL indicated that parents of LT re-
cipients reported a greater impact on time (p = 0.0001) and
emotions (p = 0.0001) than parents of children in the gen-
eral population (Table 5). With regard to parenting stress,
parents of LT recipients reported significantly higher scores
on the PIP Total-Frequency (p = 0.029) and Total-Difficulty
scales (p = 0.025) than parents of children with type 1 di-
abetes, but reported comparable Total-Frequency scores
(p = 0.22), and significantly lower scores on the Total-
Difficulty scale (p = 0.0001) than parents of children with
cancer.
Family functioning
On the CHQ-PF50 family activities subscale, parents re-
ported significantly lower scores than norms for the gen-
eral population (p = 0.0001), though scores for family cohe-
sion were similar (Table 5). On the FAD, no significant differ-
ences were found between families of LT recipients and
published norms for nonclinical families or families with
medically ill members. Likewise, on the FES, no significant
differences were found between families of LT recipients
and published norms for the general population.
Adherence behavior
Participants had an average of 7.54 ± 6.2 blood levels of
tacrolimus in the year prior to study participation (range 1–
27). The mean tacrolimus SD was 3.15 ± 3.3 ng/mL (range
0.38–19.30 ng/mL). Participants attended an average of
78.7 ± 18.3% of scheduled clinic visits (range 37.5–100%).
There was no significant relationship between tacrolimus
SD and the rate of clinic attendance, suggesting that these
measures assess different aspects of regimen adherence.
As such, participants were classified categorically as ‘ad-
herent’ and ‘nonadherent’ with respect to tacrolimus SD
and rate of clinic attendance. Forty-two percent (n = 16)
of participants were classified as nonadherent based on
tacrolimus SD > 2.5, and 50% (n = 19) were nonadherent
based on a rate of clinic attendance of <80%.
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Table 6: CBCL summary, subscale and competency scales compared to normative sample
LT recipients Compared to normative Percent of LT recipients
Mean ± SD sample (T = 50) exceeding clinical cutoffs∗
Anxious/depressed 55.62 ± 7.30 p = 0.0001 27
Withdrawn/depressed 55.65 ± 6.70 p = 0.0001 21.6
Somatic complaints 57.76 ± 7.28 p = 0.0001 24.3
Social problems 56.46 ± 7.16 p = 0.0001 25
Thought problems 57.93 ± 8.17 p = 0.0001 35
Attention problems 57.19 ± 8.55 p = 0.0001 18.9
Rule breaking behavior 55.11 ± 6.6 p = 0.0001 17.8
Aggressive behavior 55.84 ± 8.15 p = 0.0001 18.9
DSM-IV affective problems 58.11 ± 7.91 p = 0.0001 32.4
DSM-IV anxiety problems 56.27 ± 7.56 p = 0.0001 29.7
DSM-IV somatic problems 57.39 ± 7.37 p = 0.0001 25
DSM-IV ADHD 55.90 ± 6.87 p = 0.0001 18.9
DSM-IV oppositional defiant 55.24 ± 6.57 p = 0.0001 16.2
DSM-IV conduct problems 55.71 ± 7.35 p = 0.0001 21.4
Total problems 52.97 ± 12.66 p = 0.162 32.4
Internalizing problems 53.89 ± 10.40 p = 0.029 21.6
Externalizing problems 50.92 ± 12.23 p = 0.650 18.9
Activity competency 41.04 ± 10.38 p = 0.0001 35.7
Social competency 41.73 ± 10.42 p = 0.0001 34.6
School competency 40.22 ± 8.85 p = 0.0001 39
∗NOTE: 7% of the normative sample exceeds clinical cutoffs of T > 63 on summary and clinical subscales, and T < 37 on competency
scales (16).
Health status
Within the 12 months prior to participation, 26.3% of the
participants had been hospitalized at least once, 18.4%
underwent at least one liver biopsy and 10.5% had a docu-
mented biopsy-proven episode of rejection. There were 22
hospital admissions, 96 inpatient days, 7 liver biopsies and
4 biopsy-proven episodes of rejection. At the time of par-
ticipation, 3 participants had evidence of graft dysfunction
as defined by total bilirubin >2. Two of these three partici-
pants had documented nonadherence that led to graft dys-
function, and one participant had severe graft dysfunction
of unknown etiology. Two participants had percutaneous
transhepatic cholangiography (PTC) tubes at the time of
participation for biliary strictures.
Relationship between child, parent and family
functioning and adherence behavior
The distribution of the tacrolimus SD values significantly
deviated from normal, thus nonparametric Spearman cor-
relations were conducted to examine relationships with
psychosocial and health outcome measures.
Correlations with HRQOL and behavioral functioning:
Tacrolimus SD was not significantly related to measures of
child HRQOL or behavioral functioning. The rate of clinic at-
tendance was significantly related to parent-proxy reports
of child physical HRQOL (CHQ-PF50, r = 0.36, p = 0.045).
These associations remained significant after controlling
for a child’s age and the time since transplantation.
Correlations with parent functioning: Tacrolimus SD
was significantly related to impact on parent emotional
functioning as it relates to their child’s status (CHQ-PF50,
rho = –0.341, p = 0.042). The rate of clinic attendance
was significantly associated with overall illness-related par-
enting stress as measured by the PIP, including the diffi-
culty of stressful events related to the child’s medical care
(r = –0.41, p = 0.017), communication with the child and
healthcare team (r = –0.39, p = 0.23) and role functioning
(r = –0.44, p = 0.008). These associations remained signif-
icant after controlling for a child’s age and the time since
transplantation.
Correlations with family functioning: Tacrolimus SD
was not significantly related to measures of family func-
tioning. The rate of clinic attendance was significantly
related to family cohesion (CHQ-PF50, r = 0.46, p =
0.009) and family problem-solving (FAD, r = 0.41, p =
0.021).
Relationship between adherence behaviors
and health outcomes
Tacrolimus SD was significantly correlated with the fre-
quency of hospital admissions (rho = 0.47, p = 0.004),
duration of hospitalizations (rho = 0.39, p = 0.02), and liver
biopsies (rho = 0.34, p = 0.043). The rate of clinic atten-
dance was significantly correlated with hospital admissions
(r = –0.51, p = 0.001), duration of hospitalization (r = –
0.511, p = 0.001), liver biopsies (r = –0.42, p = 0.01), and
rejection episodes (r = –0.36, p = 0.026).
Differences between ‘adherent’
and ‘nonadherent’ participants
Table 7 provides a summary of the differences between
adherent and nonadherent group with respect to child, par-
ent, family and health outcome variables.
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Table 7: Comparison of adherent vs. nonadherent participants
Tacrolimus SD Rate of Clinic Attendance
Nonadherent Adherent Nonadherent Adherent
Factor (mean ± SD) (mean ± SD) p-Value (mean ± SD) (mean ± SD) p-Value
CHQ-PF50 Parent Impact-Emotional 32.29 ± 31.16 57.54 ± 28.0 p = 0.014 – – n.s
CHQ-PF50 Family cohesion 61.9 ± 28.2 77.7 ± 14.1 p = 0.035 61.3 ± 24.3 81.4 ± 14.9 p = 0.005
CHQ-PF50 Role/Social limitations, 60.7 ± 33.8 81.3 ± 24.6 p = 0.048 – – n.s.
Emotional-Behavioral
PIP Role functioning – – n.s. 25.5 ± 6.8 20.7 ± 5.9 p = 0.028
Hospital admissions 1.19 ± 1.86 0.14 ± 0.36 p = 0.017 1.00 ± 1.76 0.16 ± 0.37 p = 0.049
(total = 77) (total = 19) (total = 89) (total = 7)
Liver biopsies 0.44 ± 0.62 0.19 ± 0.40 p = 0.012 0.32 ± 0.59 0.11 ± 0.31 n.s.
Total = 7 Total = 1 Total = 6 Total = 2
Rejection episodes 0.19 ± 0.40 0.04 ± 0.22 n.s 0.21 ± 0.42 0 p = 0.035
Total = 3 Total = 1 Total = 4
Tacrolimus SD: Compared to parents in the adherent
group, parents in the nonadherent group reported a greater
impact on their emotional functioning (CHQ-PF50, p =
0.014), and significantly lower family cohesion (CHQ-PF50,
p = 0.035). Moreover, parents in the nonadherent group re-
ported that their children had significantly more role/social
limitations as a result of emotional/behavioral difficulties
(CHQ-PF50; p = 0.048). Participants in the nonadherent
group had significantly more hospital admissions (p =
0.017) and liver biopsies (p = 0.012) than the adherent
group.
Rate of clinic attendance: Compared to parents in the ad-
herent group, parents in the nonadherent group reported
more stress related to role functioning (PIP, p = 0.028), and
significantly lower family cohesion (CHQ-PF50, p = 0.005).
There were no between-group differences with respect to
child HRQOL or behavioral functioning. Participants in the
nonadherent group had significantly more hospital admis-
sions (p = 0.049) and rejection episodes (p = 0.035) than
the adherent group.
Discussion
Previous research with other pediatric chronic illness
groups have documented the link between child behavior
problems, parental psychological distress, family distress
and regimen nonadherence (11,13,27). Yet, the relation-
ship between these variables and post-transplant adher-
ence among pediatric LT recipients has not been inves-
tigated. Given the severe consequences associated with
nonadherence, the current study aimed to use empirically
sound psychological assessment measures to identify cor-
relates of nonadherence which could be targeted in an in-
tervention to improve adherence and clinical outcomes. It
was hypothesized that poor child HRQOL, poor parent and
child psychological functioning and disrupted family func-
tioning would be associated with nonadherence, and in-
creased rates of nonadherence would be related to poor
health outcomes. Results of the current study supported
these hypotheses. Specifically, nonadherence was related
to lower physical HRQOL, more limitations in social and
school activities related to emotional and behavioral prob-
lems, greater impact on parental emotional functioning,
and decreased family cohesion. Moreover, nonadherence
was related to frequency and duration of hospitalizations,
liver biopsies and rejection episodes.
In the current study, rates of nonadherence ranged from
42% to 50%. These rates are striking, and are consistent
with estimates of rates of nonadherence with medical reg-
imens among general pediatric (5,13) and pediatric LT pop-
ulations (3,4). With respect to the relationship between
adherence and health outcomes, tacrolimus SD was sig-
nificantly related to the number of hospital admissions,
duration of hospitalizations and liver biopsies. The rate of
clinic attendance was significantly correlated with hospi-
tal admissions, duration of hospitalization, liver biopsies
and rejection episodes. There continues to be a lack of
a gold standard with respect to measuring adherence to
prescribed post-transplant medical regimens. Electronic
medication monitoring technology, such as the Medica-
tion Event Monitoring System (MEMS®; Aprex Corpora-
tion, Union City, CA), is considered to be the recommended
measure in adherence research; however, this technology
has not been well studied in pediatric transplant popu-
lations. Moreover, there are barriers associated with the
MEMS technology including cost, the inability to use with
liquid medications, and the possibility that these devices
may interfere with established adherence routines, such
as the use of pillbox organizers. Indeed, this current study
proposed the use of MEMS caps, but only three families
consented to their use. Data on these three families were
not reported due to the small sample size. The majority
of families cited barriers including use of liquid medication,
the size of the MEMS TrackCap and the potential disruption
of their existing organizational system.
Shemesh and colleagues found that tacrolimus SD were
predictive of health outcomes such as liver biopsies and
episodes of rejection (10,11). Thus, they concluded that
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tacrolimus SDs were fairly specific predictors of clinically
relevant nonadherence rather than nonspecific predictors
of poor outcome. The current study failed to find a rela-
tionship between tacrolimus blood levels and documented
episodes of rejection. One possible explanation could be
the small sample size and infrequent occurrence of rejec-
tion within the current sample. Yet, this also raises the
question as to whether tacrolimus SD is a valid and re-
liable technique to measure adherence behavior. Further
study examining reliable and valid measures of regimen
adherence in pediatric transplantation is warranted.
The results of the present study extended previous work
by demonstrating that within the first 5 years following
transplant, parent-proxy and child self-reports indicate that
the HRQOL of LT recipients is adversely affected in all ar-
eas of functioning when compared with normative data
for healthy children, and was impaired with respect to
school functioning when compared to children with other
chronic illnesses. The convergence between parent and
child reports of HRQOL was striking, and clearly strength-
ens the findings of this study. Moreover, study participants
had a disproportionately higher level of attention, conduct
and emotional problems compared to the general popu-
lation, and evidenced poor competencies in life activities,
social function and school. More than half of the partic-
ipants were in the clinically significant range on at least
one area of problem behavior. Yet, despite reports of de-
creased HRQOL, increased behavioral/emotional problems
and decreased competencies, there were few significant
relationships with measure of adherence.
Though there was the lack of significance between most
measures of child functioning and adherence, it is possi-
ble that children who experience high rates of problem-
atic behavior may cause their parents and family to ex-
perience high levels of stress. Alternatively, high rates of
parental stress may be associated with inconsistent par-
enting styles which may exacerbate child behavior prob-
lems and family conflict. Moreover, both children and par-
ents may be negatively impacted by the child’s medical
condition. Thus, although most measures of child HRQOL
and behavior problems were not significantly related to ad-
herence, it is important to focus on child functioning given
the impact on parent and family functioning. Further, little
is known regarding the long-term impact of such behavior
problems on adherence.
It is widely accepted that parenting a chronically ill child is
taxing emotionally, socially and financially. However, the re-
lationship between parenting stress and health outcomes
among pediatric transplant recipients is not well under-
stood. Intervening at the parent and family level may lead to
improved health outcomes; yet, before interventions can
be developed, we need a better understanding of the rela-
tionship between parent and family functioning and health
outcomes. In the present study, parenting stress and fam-
ily cohesiveness were significantly related to measures of
adherence behavior. Specifically, parents of LT recipients
reported a greater impact on time and emotions than did
parents of children in the general population, and reported
a high level of stress related to caring for a child with a
medical condition. Parenting stress was significantly re-
lated to poor adherence. Likewise, the extent to which
family members get along with each other was also related
to adherence. These findings are consistent with research
investigating correlates of nonadherence with other pedi-
atric chronic illness groups (13).
The current study was limited by its small sample size and
single transplant center. Moreover, though the participants
were homogeneous with respect to time since transplant
(i.e. within 5 years), the sample was heterogeneous with
respect to age and diagnosis. This may further impact ad-
herence and HRQOL. In addition, there may have been a
selection bias present wherein patients and families who
are nonadherent did not participate. This selection bias
is present in many studies investigating regimen adher-
ence (5). The retrospective, cross-sectional nature of this
study also precludes us from making conclusions regard-
ing causality. The current study reports the association be-
tween parent and family stress, and poor health outcomes
(i.e. rejection), but the direction of these relationships re-
main unclear. It is likely that parent and family stress is
multifactorial related to the child’s health status, as well
as other environmental or pre-existing factors, such as so-
cioeconomic status. Prospective longitudinal studies are
required to identify impact of child, parent and family func-
tioning on adherence and health outcomes.
Despite limitations, this study has significant clinical im-
plications. Nonadherence was significantly related to as-
pects of parenting stress and family cohesiveness. Em-
pirically based assessment of modifiable factors will help
identify patients at risk for nonadherence, and may allow
for the appropriate delivery of interventions to ameliorate
this risk. Interventions should not only directly target adher-
ence behaviors such as pill taking and clinic attendance, but
should also focus on parent and family variables as these
factors were significantly related to nonadherence rates.
Specifically, future interventions should target parent cop-
ing, communication, stress management, and support in
daily roles and responsibilities.
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